Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2020.1781089
Abstract: ABSTRACT Objectives Our objective was to analyze potential drug interactions (PDIs) between targeted OAAs and concomitant therapy in clinical practice. Methods A cross-sectional observational study was performed in cancer outpatients who started treatment with a… read more here.
Keywords: drug interactions; clinical practice; concomitant medication; drug ... See more keywords
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2021 at "ERJ Open Research"
DOI: 10.1183/23120541.00778-2020
Abstract: Asthma is a chronic inflammatory condition that affects 3.8 million Canadians and nearly 65 000 acute asthma exacerbations occur each year [1–4]. Left untreated, asthma can lead to increasing mortality and morbidity [2, 5, 6]. Economically, the… read more here.
Keywords: therapy concomitant; use; concomitant medication; canada ... See more keywords
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors.
Sign Up to like & getrecommendations! Published in 2020 at "Immunotherapy"
DOI: 10.2217/imt-2019-0064
Abstract: Aim: Patients receiving checkpoint inhibitors (CPI) are frequently on other medications for co-morbidities. We explored the impact of concomitant medication use on outcomes. Materials & methods: 210 metastatic cancer patients on CPI were identified and association… read more here.
Keywords: checkpoint inhibitors; use; concomitant medication; impact concomitant ... See more keywords
Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.836934
Abstract: There are multiple approved indications for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors. Polypharmacy, defined as the use of ≥ 5 medications, is common among cancer patients. The impact of these non-oncologic… read more here.
Keywords: immune checkpoint; toxicity; efficacy; concomitant medication ... See more keywords